Clovis Oncology, Inc. Active Patents
2 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2018-03-14: Application 15920643; Invention High Dosage Strength Tablets of Rucaparib; Applicant Clovis Oncology, Inc.; Status Patented Case.
- 2015-08-17: Application 14828065; Invention High Dosage Strength Tablets of Rucaparib; Applicant Clovis Oncology, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-03-14 | 15920643 | High Dosage Strength Tablets of Rucaparib | Clovis Oncology, Inc. | Patented Case | 2018-11-20 | 10130636 | US20180200260A1 | Jeffrey Etter | United States | SPRINGER, STEPHANIE K |
| 2015-08-17 | 14828065 | High Dosage Strength Tablets of Rucaparib | Clovis Oncology, Inc. | Patented Case | 2018-06-05 | 9987285 | US20160051561A1 | Jeffrey Etter | United States | SPRINGER, STEPHANIE K |